A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 13, Issue 1, Pages 14-27
Publisher
Oxford University Press (OUP)
Online
2010-11-13
DOI
10.1093/neuonc/noq148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
- (2014) Daniel J. Klionsky et al. Autophagy
- Viruses and arrested autophagosome development
- (2014) Matthew P. Taylor et al. Autophagy
- Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15
- (2014) Xing-gang Mao et al. Translational Oncology
- Autophagy is involved in influenza A virus replication
- (2009) Zhi Zhou et al. Autophagy
- Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma
- (2009) Tracy-Ann Read et al. CANCER CELL
- Multipotent CD15+ Cancer Stem Cells in Patched-1-Deficient Mouse Medulloblastoma
- (2009) R. J. Ward et al. CANCER RESEARCH
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- Targeting Cancer-initiating Cells With Oncolytic Viruses
- (2009) Timothy P Cripe et al. MOLECULAR THERAPY
- Oncolytic Reovirus Effectively Targets Breast Cancer Stem Cells
- (2009) Paola Marcato et al. MOLECULAR THERAPY
- CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
- (2009) Yirui Sun et al. PLoS One
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystallization and preliminary X-ray diffraction studies of Seneca Valley Virus-001, a new member of thePicornaviridaefamily
- (2008) Sangita Venkataraman et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- Gene therapy progress and prospects cancer: oncolytic viruses
- (2008) T-C Liu et al. GENE THERAPY
- Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus
- (2008) L. M. Hales et al. JOURNAL OF GENERAL VIROLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Autophagosome Supports Coxsackievirus B3 Replication in Host Cells
- (2008) J. Wong et al. JOURNAL OF VIROLOGY
- Enhancing the Reliability and Throughput of Neurosphere Culture on Hydrogel Microwell Arrays
- (2008) Myriam Cordey et al. STEM CELLS
- Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma
- (2008) Qin Shu et al. STEM CELLS
- Structure of Seneca Valley Virus-001: An Oncolytic Picornavirus Representing a New Genus
- (2008) Sangita Venkataraman et al. STRUCTURE
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started